Stimulation of brain glucose uptake by cannabinoid CB2 receptors and its therapeutic potential in Alzheimer’s disease. (2016).
The influence of cannabinoids on generic traits of neurodegeneration. (2013).

Synthetic cannabinoids in dementia with agitation: case studies and literature review. (2013).

Author(s): Shabbir Amanullah, Kristin MacDougall, Nichole Sweeney, Joan Coffin, Julie Cole.

A synthetic cannabinoid known as Nabilone improved psychomotor agitation, aggression and communication in patients with dementia, thus demonstrating the potential of cannabinoids in the treatment of these disorders. View study